Dapagliozin Propanediol
If you find any inaccurate information, please let us know by providing your feedback here
Tóm tắt nội dung
This article is compiled based on the United States Pharmacopeia (USP) – 2025 Edition
Issued and maintained by the United States Pharmacopeial Convention (USP)
DOWNLOAD PDF HERE
1 DEFINITION
Dapagliozin Propanediol contains NLT 98.0% and NMT 102.0% of dapagliozin (C21H25ClO6) calculated on the anhydrous, propanediol-free, and solvent-free basis.
2 IDENTIFICATION
A. Spectroscopic Identification Tests 〈197〉, Infrared Spectroscopy: 197A or 197K
B. The retention time of the major peak of the Sample solution corresponds to that of the Standard solution, as obtained in the Assay.
3 ASSAY
3.1 Procedure
Solution A: Triuoroacetic acid and water (0.5: 1000)
Solution B: Triuoroacetic acid and acetonitrile (0.5: 1000)
Mobile phase: See Table 1.
Table 1
Time (min) | Solution A (%) | Solution B (%) |
| 0 | 85 | 15 |
| 2 | 85 | 15 |
| 36 | 10 | 90 |
| 39 | 10 | 90 |
| 40 | 85 | 15 |
| 45 | 85 | 15 |
Standard solution: 0.2 mg/mL of USP Dapagliozin Propanediol RS in acetonitrile
Sample solution: 0.2 mg/mL of Dapagliozin Propanediol in acetonitrile
Chromatographic system
(See Chromatography 〈621〉, System Suitability.)
Mode: LC
Detector: UV 220 nm
Column: 4.6-mm × 15-cm; 3.5-µm packing L1
Column temperature: 30°
Flow rate: 1 mL/min
Injection volume: 10 µL
System suitability
Sample: Standard solution
Suitability requirements
Tailing factor: 0.8–1.5
Relative standard deviation: NMT 0.85% for 6 injections
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of dapagliozin (C21H25ClO6) in the portion of Dapagliozin Propanediol taken:
Result = (ru/rs) × (Cs/Cu) × 100
ru = peak response of dapagliozin from the Sample solution
rs = peak response of dapagliozin from the Standard solution
Cs = concentration of USP Dapagliozin Propanediol RS in the Standard solution (mg/mL)
Cu = concentration of Dapagliozin Propanediol in the Sample solution (mg/mL)
Acceptance criteria: 98.0%–102.0% on the anhydrous, propanediol-free, and solvent-free basis
4 OTHER COMPONENTS
4.1 Content of Propanediol
Internal standard solution: 2.64 mg/mL of USP Ethylene Glycol RS in dimethylacetamide
Standard solution: 3.0 mg/mL of USP Propylene Glycol RS in Internal standard solution
Sample solution: 20 mg/mL of Dapagliozin Propanediol in Internal standard solution
Chromatographic system
(See Chromatography 〈621〉, System Suitability.)
Mode: GC
Detector: Flame ionization
Column: 0.32-mm × 15-m fused silica; coated with a 0.5-µm lm of phase G14. [Note—Phases of G15, G16, G20, or G39 may also be suitable for use.]
Temperatures
Injection port: 240°
Detector: 240°
Column: See Table 2.
Table 2
Initial Temperature (°) | Temperature Ramp (°/min) | Final Temperature (°) | Hold Time at Final Temperature (min) |
| 150 | — | 150 | 2 |
| 150 | 40 | 240 | 4 |
Carrier gas: Helium
Flow rate: 3.5 mL/min
Injection volume: 1.0 µL
Injection type: Split, split ow 80.8 mL/min
Run time: NLT 5 times the retention time of propanediol
System suitability
Sample: Standard solution
[Note—The relative retention times for propanediol and ethylene glycol are 1.0 and 1.1, respectively.]
Suitability requirements
Resolution: NLT 1.5 between propanediol and ethylene glycol
Relative standard deviation: NMT 3.0% for propanediol and ethylene glycol
Analysis
Samples: Standard solution and Sample solution
Calculate the percentage of propanediol in the portion of Dapagliozin Propanediol taken:
Result = (Ru/Rs) × (Cs/Cu) × 100
Ru = peak response ratio of propanediol to ethylene glycol from the Sample solution
Rs = peak response ratio of propanediol to ethylene glycol from the Standard solution
Cs = concentration of USP Propylene Glycol RS in the Standard solution (mg/mL)
Cu = concentration of Dapagliozin Propanediol in the Sample solution (mg/mL)
Acceptance criteria: 14.0%–16.5%
5 IMPURITIES
5.1 Organic Impurities
Solution A, Solution B, Mobile phase, Standard solution, Sample solution, and Chromatographic system: Proceed as directed in the Assay. Sensitivity solution: 0.1 µg/mL of USP Dapagliozin Propanediol RS in acetonitrile
System suitability solution: 0.2 mg/mL of USP Dapagliozin Propanediol RS and 0.007 mg/mL of USP Dapagliozin Related Compound A RS in acetonitrile
System suitability
Samples: Standard solution, Sensitivity solution, and System suitability solution
[Note—The relative retention times for dapagliozin and dapagliozin related compound A are 1.0 and 1.02, respectively.] Suitability requirements
Resolution: NLT 2.0 between dapagliozin and dapagliozin related compound A, System suitability solution
Tailing factor: 0.8–1.5 for dapagliozin, Standard solution
Signal-to-noise ratio: NLT 10, Sensitivity solution
Analysis
Sample: Sample solution
Calculate the percentage of each individual impurity in the portion of Dapagliozin Propanediol taken:
Result = (rU/rT) × 100
rU = peak response of each individual impurity from the Sample solution
rT = sum of all the responses from the Sample solution
Acceptance criteria: See Table 3. The reporting threshold is 0.05%.
Table 3
| Name | Relative Retention Time | Acceptance Criteria, NMT (%) |
| Dapagliozin | 1.0 | — |
| Ethyldapagliozin | 1.24 | 0.15 |
| Any individual unspecied impurity | — | 0.10 |
| Total impurities | — | 0.30 |
a (2S,3R,4R,5S,6R)-2-[4-Chloro-3-(4-ethoxy-3-ethylbenzyl)phenyl]-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol.
6 SPECIFIC TESTS
Water Determination 〈921〉, Method I, Method Ic: 3.2%–4.0%
7 ADDITIONAL REQUIREMENTS
Packaging and Storage: Preserve in a well-closed container. Store at controlled room temperature.
USP Reference Standards 〈11〉
USP Dapagliozin Propanediol RS
USP Dapagliozin Related Compound A RS
(2S,3R,4R,5S,6R)-2-[4-Bromo-3-(4-ethoxybenzyl)phenyl]-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol.
C21H25BrO6 453.33
USP Ethylene Glycol RS
Ethane-1,2-diol.
C2H6O2 62.07
USP Propylene Glycol RS
Propane-1,2-diol.
C3H8O2 76.10 (USP 1-Dec-2023)

